ASX:PYC PYC Therapeutics (PYC) Stock Price, News & Analysis → A lot of people are making this costly mistake (From WealthPress) (Ad) Free PYC Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield9.46%Price TargetN/A Stock AnalysisStock Analysis Get PYC Therapeutics alerts: Email Address Ad Crypto 101 MediaCrypto Market Preps For Trillions Worth of Inflows! Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.Click to join the Crypto Community Summit Free Online Event About PYC TherapeuticsPYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of RNA therapeutics in Australia. The company's preclinical development programs include VP-001, a drug program for retinitis pigmentosa type 11; PYC-001, a drug program for the treatment of autosomal dominant optic atrophy; and PYC-002 a drug program for the treatment of a severe neurodevelopmental disorder. It also focuses on the development of programs for kidney, neurodevelopmental, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.Read More Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here PYC Stock News HeadlinesAugust 11, 2023 | finance.yahoo.comUS FDA DESIGNATES PYC'S LEAD AS A FAST TRACK DEVELOPMENT PROGRAMJuly 24, 2023 | au.finance.yahoo.comPYC.AX - PYC Therapeutics LimitedMarch 29, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. July 17, 2023 | msn.comASX Health Stocks: Successful toxicology tests pave the way for PYC’s Phase 2 clinical trialJuly 15, 2023 | finance.yahoo.comNon-Executive Chair of the Board of PYC Therapeutics Alan Tribe Buys 26% More SharesMarch 5, 2023 | msn.comASX Health Stocks: Rhythm crashes 45pc after withdrawing TGA application for ColoSTATJanuary 13, 2023 | finance.yahoo.comOwning 50% in PYC Therapeutics Limited (ASX:PYC) means that insiders are heavily invested in the company's futureDecember 23, 2022 | nz.finance.yahoo.comPYC Therapeutics Limited (ASX:PYC) insider upped their holding by 0.2% earlier this yearMarch 29, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.November 22, 2022 | finance.yahoo.comWill PYC Therapeutics (ASX:PYC) Spend Its Cash Wisely?September 14, 2022 | finance.yahoo.comPYC Therapeutics Limited (PYC.AX)August 16, 2022 | reuters.comPYC Therapeutics LtdAugust 8, 2022 | nz.finance.yahoo.comAHF Sounds ‘Monkeypox: LA County Alert’ in Latest LA Times AdAugust 8, 2022 | nz.finance.yahoo.comBond Traders on Collision Course With Fed Over Longer-Term ViewJune 7, 2022 | finance.yahoo.comWe're Hopeful That PYC Therapeutics (ASX:PYC) Will Use Its Cash WiselyMay 9, 2022 | finance.yahoo.comThose who invested in PYC Therapeutics (ASX:PYC) three years ago are up 256%March 2, 2022 | news.yahoo.comHow to Increase the Competitive Advantage of Your Small to Midsize BusinessMarch 1, 2022 | news.yahoo.comKillearn Golf & Country Club on verge of new ownership, 'massive revitalization' on horizonFebruary 27, 2022 | finance.yahoo.comWhat Is The Ownership Structure Like For PYC Therapeutics Limited (ASX:PYC)?February 23, 2022 | lse.co.ukShield Thera Share ChatJanuary 24, 2022 | msn.comBritain To Test Merck - Ridgeback Biotherapeutics' COVID-19 Antiviral Pill In Hospitalized PatientsDecember 30, 2021 | finance.yahoo.comPYC Therapeutics Limited (ASX:PYC) insider upped their holding by 0.06% earlier this yearNovember 15, 2021 | finance.yahoo.comCompanies Like PYC Therapeutics (ASX:PYC) Are In A Position To Invest In GrowthSee More Headlines Receive PYC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PYC Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:PYC CUSIPN/A CIKN/A Webpyctx.com Phone61 8 6151 0992FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-21,650,000.00 Net Margins-101.90% Pretax MarginN/A Return on Equity-80.66% Return on Assets-38.38% Debt Debt-to-Equity Ratio1.77 Current Ratio3.98 Quick Ratio8.93 Sales & Book Value Annual Sales$21.24 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares3,780,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.63 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Rohan Hockings G.D.L.P (Age 41)J.D., MBBS, MBBS (Hons.), CEO & Executive Director Comp: $437.5kMr. Andrew Taylor B.Com.C.A., CFO & Company SecretaryMr. Kevin Ronald Hart B.Com. (Age 62)B.Comm (Hons), C.A., F.C.A., Company Secretary Comp: $165.9kKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersRohan HockingsSold 18,181,818 sharesTotal: $1.82 M ($0.10/share)Alan TribeSold 254,545,459 sharesTotal: $14.00 M ($0.06/share)Rohan HockingsSold 18,181,818 sharesTotal: $999,999.99 ($0.06/share)Alan TribeBought 82,610 shares on 6/29/2023Total: $4,378.33 ($0.05/share)Alan TribeBought 1,590,767 shares on 6/26/2023Total: $84,310.65 ($0.05/share) This page (ASX:PYC) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PYC Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.